Clinical Trials Browser

INDUSTRY × Interventional × Chronic Pain × Clear all

Cancer Pain, Back Pain, Pain, Intractable, Chronic Pain

NCT01964378 2021-07-15

CORAL

Phase 3 Terminated

200 enrolled 37 charts

Cancer Pain, Neoplasms, Pain, Chronic Pain

NCT02031432 2021-07-15

CORAL XT

Phase 3 Completed

76 enrolled 36 charts

Cancer Pain, Neoplasms, Pain, Chronic Pain

NCT02367820 2021-06-22

SUMMIT-LTS

Phase 3 Completed

638 enrolled 12 charts

Low Back Pain, Chronic Pain

NCT01264887 2019-11-04

Tapentadol in Chronic Malignant Tumour Related Pain

Phase 3 Terminated

31 enrolled 19 charts

Agnosia, Neoplasms, Pain, Chronic Pain

NCT03522467 2019-09-25

COPE

Phase 2 Unknown

40 enrolled

Marijuana Abuse, Neoplasms, Pain, Chronic Pain

NCT00696137 2019-09-24

Long-term Extension Study of BEMA™ Fentanyl

Phase 3 Completed

5 enrolled 4 charts

Respiratory Insufficiency, Chronic Pain

NCT02603705 2018-03-05

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

Phase 3 Completed

281 enrolled

Chronic Pain

NCT02232256 2017-04-26

CALPXT96

Phase 3 Withdrawn

Sleep Initiation and Maintenance Disorders, Pain, Chronic Pain

NCT01185470 2017-04-24

The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain

Phase 2/3 Completed

75 enrolled

Neoplasms, Chronic Pain

NCT03105765 2017-04-10

Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.

Phase NA Completed

200 enrolled

Neuralgia, Chronic Pain, Acute Pain

NCT00943566 2015-09-15

A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer

Phase 2 Withdrawn

Neoplasms, Pain, Chronic Pain

NCT01902524 2014-08-28

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

Phase 4 Completed

65 enrolled

Chronic Pain

NCT00984334 2013-12-27

Naloxone SR Capsules in Patients With Opioid Induced Constipation

Phase 2 Completed

40 enrolled 12 charts

Other

Opioid-Induced Constipation, Constipation, Pain, Chronic Pain

NCT01206907 2012-08-17

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Phase 3 Withdrawn

Classical hematology

Anemia, Sickle Cell, Arthritis, Juvenile, Neoplasms, Chronic Pain

NCT01100437 2012-07-13

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Phase 4 Terminated

14 enrolled 18 charts

Substance Withdrawal Syndrome, Chronic Pain

NCT00126789 2012-06-05

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Phase 3 Terminated

24 enrolled

Cancer Pain, Neoplasms, Pain, Chronic Pain

NCT00410748 2010-04-27

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

Phase 3 Completed

388 enrolled

Pain, Chronic Pain

NCT00911261 2010-02-15

Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain

Phase 3 Completed

223 enrolled

Cancer Pain, Neoplasms, Neuralgia, Chronic Pain

Clinical Trials

Prometra Post-Approval Study

CORAL

CORAL XT

SUMMIT-LTS

Tapentadol in Chronic Malignant Tumour Related Pain

COPE

Long-term Extension Study of BEMA™ Fentanyl

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

CALPXT96

The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain

Acute and Chronic Pain, Especially Neuropathic Pain, After Thoracotomy and Continuous Application of Ketamine.

A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer

Efficacy and Safety Study of Fentanyl Transdermal Patch for Treatment of Chronic Pain

Naloxone SR Capsules in Patients With Opioid Induced Constipation

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain